BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Guo XY, Sun F, Chen JN, Wang YQ, Pan Q, Fan JG. circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling. World J Gastroenterol 2018; 24(3): 323-337 [PMID: 29391755 DOI: 10.3748/wjg.v24.i3.323]
URL: https://www.wjgnet.com/1948-5182/full/v24/i3/323.htm
Number Citing Articles
1
Xueyuan Sun, Kaiyuan Deng, Yunhui Zang, Zhiyong Zhang, Boxin Zhao, Jingyao Fan, Lijuan Huang. Exploring the regulatory roles of circular RNAs in the pathogenesis of atherosclerosisVascular Pharmacology 2021; 141: 106898 doi: 10.1016/j.vph.2021.106898
2
Alan Eduardo Botello-Manilla, Norberto Carlos Chávez-Tapia, Misael Uribe, Natalia Nuño-Lámbarri. Genetics and epigenetics purpose in nonalcoholic fatty liver diseaseExpert Review of Gastroenterology & Hepatology 2020; 14(8): 733 doi: 10.1080/17474124.2020.1780915
3
Yishan Ge, Wenwu Liu, Wei Yin, Xuebin Wang, Jie Wang, Xiaoqing Zhu, Shengkai Xu. Circular RNA circ_0090231 promotes atherosclerosis in vitro by enhancing NLR family pyrin domain containing 3-mediated pyroptosis of endothelial cellsBioengineered 2021; 12(2): 10837 doi: 10.1080/21655979.2021.1989260
4
Yiyi Zhu, Weiwei Gui, Xihua Lin, Hong Li. Knock-down of circular RNA H19 induces human adipose-derived stem cells adipogenic differentiation via a mechanism involving the polypyrimidine tract-binding protein 1Experimental Cell Research 2020; 387(2): 111753 doi: 10.1016/j.yexcr.2019.111753
5
Farooq Riaz, Dongmin Li. Non-coding RNA Associated Competitive Endogenous RNA Regulatory Network: Novel Therapeutic Approach in Liver FibrosisCurrent Gene Therapy 2019; 19(5): 305 doi: 10.2174/1566523219666191107113046
6
Sanyang Chen, Hongbo Fang, Jie Li, Jihua Shi, Jiakai Zhang, Peihao Wen, Zhihui Wang, Han Yang, Shengli Cao, Huapeng Zhang, Hongwei Tang, Wenzhi Guo, Shuijun Zhang. Microarray Analysis For Expression Profiles of lncRNAs and circRNAs in Rat Liver after Brain-Dead Donor Liver TransplantationBioMed Research International 2019; 2019: 1 doi: 10.1155/2019/5604843
7
Zheng-hua Liu, Shi-ze Yang, Wen-ya Li, Si-yuan Dong, Si-yu Zhou, Shun Xu. circRNA_141539 can serve as an oncogenic factor in esophageal squamous cell carcinoma by sponging miR-4469 and activating CDK3 geneAging 2021; 13(8): 12179 doi: 10.18632/aging.103071
8
Jesus Rivera-Aguirre, Guillermo Nahúm López-Sánchez, Norberto Carlos Chávez-Tapia, Misael Uribe, Natalia Nuño-Lámbarri. Metabolic-associated Fatty Liver Disease Regulation through Nutri Epigenetic MethylationMini-Reviews in Medicinal Chemistry 2023; 23(17): 1680 doi: 10.2174/1389557523666230130093512
9
Qingmin Zeng, Chang-Hai Liu, Javier Ampuero, Dongbo Wu, Wei Jiang, Lingyun Zhou, Hong Li, Lang Bai, Manuel Romero-Gómez, Hong Tang. Circular RNAs in non-alcoholic fatty liver disease: Functions and clinical significanceRNA Biology 2024; 21(1): 1 doi: 10.1080/15476286.2023.2290769
10
Jorge-Luis Torres, Ignacio Novo-Veleiro, Laura Manzanedo, Lucía Alvela-Suárez, Ronald Macías, Francisco-Javier Laso, Miguel Marcos. Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2018; 24(36): 4104-4118 doi: 10.3748/wjg.v24.i36.4104
11
Xiaoni Huang, Yuwen Zhao, Huijiao Zhou, Yongqiang Li. Circular RNAs in atherosclerosisClinica Chimica Acta 2022; 531: 71 doi: 10.1016/j.cca.2022.03.016
12
Siti Aishah Sulaiman, Nor I. A. Muhsin, Rahman Jamal. Regulatory Non-coding RNAs Network in Non-alcoholic Fatty Liver DiseaseFrontiers in Physiology 2019; 10 doi: 10.3389/fphys.2019.00279
13
Caterina Formichi, Laura Nigi, Giuseppina Emanuela Grieco, Carla Maccora, Daniela Fignani, Noemi Brusco, Giada Licata, Guido Sebastiani, Francesco Dotta. Non-Coding RNAs: Novel Players in Insulin Resistance and Related DiseasesInternational Journal of Molecular Sciences 2021; 22(14): 7716 doi: 10.3390/ijms22147716
14
Ruixian Huang, Xiaoyan Duan, Jangao Fan, Guangming Li, Baocan Wang. Role of Noncoding RNA in Development of Nonalcoholic Fatty Liver DiseaseBioMed Research International 2019; 2019: 1 doi: 10.1155/2019/8690592
15
Xi Jin, Jianguo Gao, Ruoheng Zheng, Mosang Yu, Yue Ren, Tianlian Yan, Yue Huang, Youming Li. Antagonizing circRNA_002581–miR-122–CPEB1 axis alleviates NASH through restoring PTEN–AMPK–mTOR pathway regulated autophagyCell Death & Disease 2020; 11(2) doi: 10.1038/s41419-020-2293-7
16
Marwa Abdelgwad, Reem Zakaria, Samar Marzouk, Dina Sabry, Rasha Ahmed, Hedy Ayman Badary, Mai Samir. The Emerging Role of Circular RNA Homeodomain Interacting Protein Kinase 3 and Circular RNA 0046367 through Wnt/Beta-Catenin Pathway on the Pathogenesis of Nonalcoholic Steatohepatitis in Egyptian PatientsReports of Biochemistry and Molecular Biology 2023; 11(4): 614 doi: 10.52547/rbmb.11.4.614
17
Jianguo Wu, Laura E. Nagy, Suthat Liangpunsakul, Li Wang. Non-coding RNA crosstalk with nuclear receptors in liver diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2021; 1867(5): 166083 doi: 10.1016/j.bbadis.2021.166083
18
Cheng Wen, Bowei Li, Lei Nie, Ling Mao, Yuanpeng Xia. Emerging Roles of Extracellular Vesicle-Delivered Circular RNAs in AtherosclerosisFrontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.804247
19
Stephen Hong, Darren Gordon, David E. Stec, Terry D. Hinds. Nuclear Receptors2021; : 463 doi: 10.1007/978-3-030-78315-0_17
20
Wenjun Yang, Jinduo Zhao, Ye Zhao, Wenfeng Li, Liang Zhao, Yi Ren, Rongying Ou, Yunsheng Xu. Hsa_circ_0048179 attenuates free fatty acid-induced steatosis via hsa_circ_0048179/miR-188-3p/GPX4 signalingAging 2020; 12(23): 23996 doi: 10.18632/aging.104081
21
Shreyoshi Guha, Selvam Sesili, Ishfaq Hassan Mir, Chinnasamy Thirunavukkarasu. Epigenetics and mitochondrial dysfunction insights into the impact of the progression of non‐alcoholic fatty liver diseaseCell Biochemistry and Function 2023; 41(1): 4 doi: 10.1002/cbf.3763
22
Cong Liu, Xilin Liu, Hong Li, Zhichen Kang. Advances in the regulation of adipogenesis and lipid metabolism by exosomal ncRNAs and their role in related metabolic diseasesFrontiers in Cell and Developmental Biology 2023; 11 doi: 10.3389/fcell.2023.1173904
23
Yueh Chien, Ping-Hsing Tsai, Ying-Hsiu Lai, Kai-Hsi Lu, Chao-Yu Liu, Heng-Fu Lin, Chi-Shuan Huang, Wai-Wah Wu, Chien-Ying Wang. CircularRNA as novel biomarkers in liver diseasesJournal of the Chinese Medical Association 2020; 83(1): 15 doi: 10.1097/JCMA.0000000000000230
24
Xianhui Zeng, Xianglei Yuan, Qiuyu Cai, Chengwei Tang, Jinhang Gao. Circular RNA as An Epigenetic Regulator in Chronic Liver DiseasesCells 2021; 10(8): 1945 doi: 10.3390/cells10081945
25
Baoyi Zhu, Zhanfang Kang, Sihua Zhu, Yuying Zhang, Xiangmao Lai, Lilin Zhou, Hai Huang, Xiaofeng Gao, Chonghe Jiang, Jianwen Zeng. Multi-Omics Characterization of Circular RNA-Encoded Novel Proteins Associated With Bladder Outlet ObstructionFrontiers in Cell and Developmental Biology 2022; 9 doi: 10.3389/fcell.2021.772534
26
Yuanyuan Zhang, Zhichen Tian, Haibo Ye, Xiaomei Sun, Huiming Zhang, Yujia Sun, Yongjiang Mao, Zhangping Yang, Mingxun Li. Emerging functions of circular RNA in the regulation of adipocyte metabolism and obesityCell Death Discovery 2022; 8(1) doi: 10.1038/s41420-022-01062-w
27
Chen Chen, Xing Zhang, Yuan Deng, Qingming Cui, Ji Zhu, Huibo Ren, Yingying Liu, Xionggui Hu, Jianbo Zuo, Yinglin Peng. Regulatory roles of circRNAs in adipogenesis and lipid metabolism: emerging insights into lipid‐related diseasesThe FEBS Journal 2021; 288(12): 3663 doi: 10.1111/febs.15525
28
Li-Da Chen, Jie-Feng Huang, Xue-Jun Lin, Ya-Ping Huang, Qiao-Zhen Xu, Gong-Ping Chen, Qi-Chang Lin. Expression profiling and functional analysis of circular RNAs in vitro model of intermittent hypoxia-induced liver injuryFrontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.972407
29
Tianhui Wang, Wen Pan, Jun Hu, Zhongrong Zhang, Guoping Li, Yajun Liang. Circular RNAsAdvances in Experimental Medicine and Biology 2018; 1087: 275 doi: 10.1007/978-981-13-1426-1_22
30
Renzhi Yao, Haifan Zou, Weijia Liao. Prospect of Circular RNA in Hepatocellular Carcinoma: A Novel Potential Biomarker and Therapeutic TargetFrontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00332
31
Guangli Yu, Zhou Yang, Tianhong Peng, Yuncheng Lv. Circular RNAs: Rising stars in lipid metabolism and lipid disordersJournal of Cellular Physiology 2021; 236(7): 4797 doi: 10.1002/jcp.30200
32
Mohamed Zaiou. Reviews on Biomarker Studies of Metabolic and Metabolism-Related DisordersAdvances in Experimental Medicine and Biology 2019; 1134: 177 doi: 10.1007/978-3-030-12668-1_10
33
Meysam Ramezani, Mahsa Zobeiry, Shahrokh Abdolahi, Behzad Hatami, Mohammad Reza Zali, Kaveh Baghaei. A crosstalk between epigenetic modulations and non-alcoholic fatty liver disease progressionPathology - Research and Practice 2023; 251: 154809 doi: 10.1016/j.prp.2023.154809
34
Yongzhi Zeng, Zhi Zheng, Fengtao Liu, Guanghui Yi. Circular RNAs in metabolism and metabolic disordersObesity Reviews 2021; 22(7) doi: 10.1111/obr.13220
35
Melissa Yepmo, Jean-Baptiste Potier, Michel Pinget, Anastasia Grabarz, Karim Bouzakri, Aurore Dumond Bourie. Discussing the role of circular RNA in the pathogenesis of non-alcoholic fatty liver disease and its complicationsFrontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1035159
36
Nan Sheng, Yitao Pan, Yong Guo, Yan Sun, Jiayin Dai. Hepatotoxic Effects of Hexafluoropropylene Oxide Trimer Acid (HFPO-TA), A Novel Perfluorooctanoic Acid (PFOA) Alternative, on MiceEnvironmental Science & Technology 2018; 52(14): 8005 doi: 10.1021/acs.est.8b01714
37
Claudia Theys, Dorien Lauwers, Claudina Perez-Novo, Wim Vanden Berghe. PPARα in the Epigenetic Driver Seat of NAFLD: New Therapeutic Opportunities for Epigenetic Drugs?Biomedicines 2022; 10(12): 3041 doi: 10.3390/biomedicines10123041
38
Xinlu Yuan, Jianjun Diao, Anqing Du, Song Wen, Ligang Zhou, Yangbin Pan. Circular RNA expression profiles and features in NAFLD mice: a study using RNA-seq dataJournal of Translational Medicine 2020; 18(1) doi: 10.1186/s12967-020-02637-w
39
Carlos Jose Pirola, Silvia Sookoian. Epigenetics factors in nonalcoholic fatty liver diseaseExpert Review of Gastroenterology & Hepatology 2022; 16(6): 521 doi: 10.1080/17474124.2020.1765772
40
Biao Li, Jinzeng Yang, Jun He, Yan Gong, Yu Xiao, Qinghua Zeng, Kang Xu, Yehui Duan, Jianhua He, Haiming Ma. Spatiotemporal Regulation and Functional Analysis of Circular RNAs in Skeletal Muscle and Subcutaneous Fat during Pig GrowthBiology 2021; 10(9): 841 doi: 10.3390/biology10090841
41
Jian Li, Jing Qi, Yishu Tang, Huaizheng Liu, Kefu Zhou, Zheren Dai, Lehong Yuan, Chuanzheng Sun. A nanodrug system overexpressed circRNA_0001805 alleviates nonalcoholic fatty liver disease via miR-106a-5p/miR-320a and ABCA1/CPT1 axisJournal of Nanobiotechnology 2021; 19(1) doi: 10.1186/s12951-021-01108-8
42
Fatemeh Kazeminasab, Maryam Baharlooie, Kamran Ghaedi, Stéphane Mandard. Noncoding RNAs Associated with PPARs in Etiology of MAFLD as a Novel Approach for Therapeutics TargetsPPAR Research 2022; 2022: 1 doi: 10.1155/2022/6161694
43
Zhaoxiong Lei, Huiguang Wu, Yan Xiong, Dawei Wei, Xingping Wang, Zhuoma Luoreng, Xiaoyan Cai, Yun Ma. ncRNAs regulate bovine adipose tissue depositionMolecular and Cellular Biochemistry 2021; 476(7): 2837 doi: 10.1007/s11010-021-04132-2
44
Qin Pan, Jian-Gao Fan, Yusuf Yilmaz. Pathogenetic Pathways in Nonalcoholic Fatty Liver DiseaseClinics in Liver Disease 2023; 27(2): 317 doi: 10.1016/j.cld.2023.01.013
45
Fanglin Wang, Xiang Li, Zhiyuan Li, Shoushuai Wang, Jun Fan. Functions of Circular RNAs in Regulating Adipogenesis of Mesenchymal Stem CellsStem Cells International 2020; 2020: 1 doi: 10.1155/2020/3763069
46
Samar A. Zailaie, Basmah B. Khoja, Jumana J. Siddiqui, Mohammad H. Mawardi, Emily Heaphy, Amjad Aljagthmi, Consolato M. Sergi. Investigating the Role of Non-Coding RNA in Non-Alcoholic Fatty Liver DiseaseNon-Coding RNA 2024; 10(1): 10 doi: 10.3390/ncrna10010010
47
Mohamed Zaiou. Peroxisome Proliferator-Activated Receptor-γ as a Target and Regulator of Epigenetic Mechanisms in Nonalcoholic Fatty Liver DiseaseCells 2023; 12(8): 1205 doi: 10.3390/cells12081205
48
Rui Jiang, Hui Li, Jiameng Yang, Xuemei Shen, Chengchuang Song, Zhaoxin Yang, Xiaogang Wang, Yongzhen Huang, Xianyong Lan, Chuzhao Lei, Hong Chen. circRNA Profiling Reveals an Abundant circFUT10 that Promotes Adipocyte Proliferation and Inhibits Adipocyte Differentiation via Sponging let-7Molecular Therapy - Nucleic Acids 2020; 20: 491 doi: 10.1016/j.omtn.2020.03.011
49
Vicneswarry Dorairaj, Siti Aishah Sulaiman, Nadiah Abu, Nor Azian Abdul Murad. Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive DiagnosisBiomedicines 2021; 10(1): 15 doi: 10.3390/biomedicines10010015
50
Tianrui Jing, Yifan Wu, Anran Wan, Chengmin Ge, Zi-Jiang Chen, Yanzhi Du. Circular RNA as a Novel Regulator and Promising Biomarker in Polycystic Ovary SyndromeBiomolecules 2023; 13(7): 1101 doi: 10.3390/biom13071101
51
Weihua Tian, Bo Zhang, Haian Zhong, Ruixue Nie, Yao Ling, Hao Zhang, Changxin Wu. Dynamic Expression and Regulatory Network of Circular RNA for Abdominal Preadipocytes Differentiation in Chicken (Gallus gallus)Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.761638
52
Xiaopeng Zhu, Mingfeng Xia, Xin Gao. Update on genetics and epigenetics in metabolic associated fatty liver diseaseTherapeutic Advances in Endocrinology and Metabolism 2022; 13: 204201882211321 doi: 10.1177/20420188221132138
53
Yong Li, Chao‐Qun Cen, Bo Liu, Lu Zhou, Xiang‐Miao Huang, Geng‐Yan Liu. Overexpression of circ PTK2 suppresses the progression of nonalcoholic fatty liver disease via the miR‐200c/SIK2/PI3K/Akt axisThe Kaohsiung Journal of Medical Sciences 2022; 38(9): 869 doi: 10.1002/kjm2.12568
54
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Abilash Valsala Gopalakrishnan, Ramkumar Katturajan, Sandra Kannampuzha, Reshma Murali, Arunraj Namachivayam, Raja Ganesan, Kaviyarasi Renu, Abhijit Dey, Balachandar Vellingiri, Sabina Evan Prince. Exploring the Regulatory Role of ncRNA in NAFLD: A Particular Focus on PPARsCells 2022; 11(24): 3959 doi: 10.3390/cells11243959
55
Yueh-Lin Wu, Hsiao-Fen Li, Hsi-Hsien Chen, Heng Lin. Emergent Roles of Circular RNAs in Metabolism and Metabolic DisordersInternational Journal of Molecular Sciences 2022; 23(3): 1032 doi: 10.3390/ijms23031032
56
Yan-Yu Peng, Dan Sun, Yan Xin. Hsa_circ_0005230 is up-regulated and promotes gastric cancer cell invasion and migration via regulating the miR-1299/RHOT1 axisBioengineered 2022; 13(3): 5046 doi: 10.1080/21655979.2022.2036514
57
Zhouxiao Li, Ye Cheng, Fan Wu, Liangliang Wu, Hongyong Cao, Qian Wang, Weiwei Tang. The emerging landscape of circular RNAs in immunity: breakthroughs and challengesBiomarker Research 2020; 8(1) doi: 10.1186/s40364-020-00204-5
58
Huili Li, Thomas Herrmann, Jessica Seeßle, Gerhard Liebisch, Uta Merle, Wolfgang Stremmel, Walee Chamulitrat. Role of fatty acid transport protein 4 in metabolic tissues: insights into obesity and fatty liver diseaseBioscience Reports 2022; 42(6) doi: 10.1042/BSR20211854
59
Wujun Chen, Yihui Liu, Ling Li, Bing Liang, Shuai Wang, Xiaodan Xu, Dongming Xing, Xiaolin Wu. The potential role and mechanism of circRNAs in foam cell formationNon-coding RNA Research 2023; 8(3): 315 doi: 10.1016/j.ncrna.2023.03.005
60
Panpan Wang, Yunhuan Zhang, Lugang Deng, Zhi Qu, Peisen Guo, Limin Liu, Zengli Yu, Peixi Wang, Nan Liu. The function and regulation network mechanism of circRNA in liver diseasesCancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02559-1
61
Guocheng Rao, Xi Peng, Yan Tian, Xianghui Fu, Yuwei Zhang. Circular RNAs in hepatocellular carcinoma: biogenesis, function, and pathologyFrontiers in Genetics 2023; 14 doi: 10.3389/fgene.2023.1106665
62
Mohamed Zaiou. Noncoding RNAs as additional mediators of epigenetic regulation in nonalcoholic fatty liver diseaseWorld Journal of Gastroenterology 2022; 28(35): 5111-5128 doi: 10.3748/wjg.v28.i35.5111
63
Meiyi Song, Lu Xia, Mengxue Sun, Changqing Yang, Fei Wang. Circular RNAsAdvances in Experimental Medicine and Biology 2018; 1087: 245 doi: 10.1007/978-981-13-1426-1_20
64
Olfa Khalifa, Khaoula Errafii, Nayla S. Al-Akl, Abdelilah Arredouani. Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis BiomarkersDisease Markers 2020; 2020: 1 doi: 10.1155/2020/8822859
65
Xiaoniu Dai, Yusi Cheng, Cuifen Wang, Jie Huang, Jie Chao. Role of circular RNAs in visceral organ fibrosisFood and Chemical Toxicology 2021; 150: 112074 doi: 10.1016/j.fct.2021.112074
66
Ramón Cacabelos, Iván Tellado, Pablo Cacabelos. Pharmacoepigenetics2019; : 1 doi: 10.1016/B978-0-12-813939-4.00001-2